Cargando…
Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
BACKGROUND: Hyperprolactinemia has been associated with changes in body composition and metabolic abnormalities. Normalization of prolactin (PRL) with dopamine agonists has been found to reverse these abnormalities. This study was designed to assess the anthropometric and metabolic alterations assoc...
Autores principales: | Pala, Nazir A., Laway, Bashir A., Misgar, Raiz A., Dar, Rayees A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650139/ https://www.ncbi.nlm.nih.gov/pubmed/26583049 http://dx.doi.org/10.1186/s13098-015-0094-4 |
Ejemplares similares
-
Profile of leptin, adiponectin, and body fat in patients with hyperprolactinemia: Response to treatment with cabergoline
por: Pala, Nazir Ahmad, et al.
Publicado: (2016) -
Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses
por: Baba, Mohammad Salem, et al.
Publicado: (2023) -
Metabolic Abnormalities, Inflammatory Markers and Endothelial Dysfunction in Hyperprolactinemia due to Prolactinoma before and after Normalization of Serum Prolactin: A Prospective Case Control Study
por: Baba, Mohammad Salem, et al.
Publicado: (2023) -
Thyroid Autoimmunity and Subclinical Hypothyroidism in Prolactinoma: A Case Control Study
por: Laway, Bashir A., et al.
Publicado: (2023) -
Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)